Repeated administration of a vitamin preparation containing glycocholic acid in patients with hepatobiliary disease

Alimentary Pharmacology & Therapeutics
K RifaiS C Bischoff

Abstract

Until now, hydrophilic and lipophilic vitamin preparations had to be administered separately during total parenteral nutrition. By addition of glycocholic acid, a vitamin supplement (Cernevit, Baxter, Heidelberg, Germany) was developed that combines all vitamins into one vial. However, little information exists about possible consequences of bile acid administration such as glycocholic acid, especially if liver disease is pre-existing. To evaluate the effects of total parenteral nutrition with a vitamin preparation containing high doses of glycocholic acid in patients with and without liver disease. In a prospective, randomized-controlled trial, 74 patients, 36 of them with hepatobiliary disease, received total parenteral nutrition for 16 +/- 11 days, either with Cernevit or control vitamin supplements. Patients were closely monitored for clinical and biochemical parameters including serum bile acid profiles measured by high-performance liquid chromatography. Serum glycocholic acid increased in patients with liver disease treated with Cernevit, whereas total bile acids did not significantly change. Other liver function tests remained stable during treatment. No adverse events during Cernevit administration were noted except for...Continue Reading

References

Jun 5, 1975·The New England Journal of Medicine·M G KormanA F Hofmann
Sep 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P R GalleA Stiehl
Jun 18, 1966·Nature·N B Javitt
Feb 14, 1984·Clinica Chimica Acta; International Journal of Clinical Chemistry·J SchoelmerichM DeLuca
Jul 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J SchölmerichW Gerok
Feb 26, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·A T Ruben, G P van Berge-Henegouwen
May 1, 1995·Journal of Pediatric Gastroenterology and Nutrition·A F Hofmann
Jul 1, 1993·Journal of Clinical Gastroenterology·M D Vadva, G Triadafilopoulos
Mar 1, 1996·JPEN. Journal of Parenteral and Enteral Nutrition·A B BallingerM J Farthing
Dec 3, 2004·Digestive Diseases and Sciences·Carlos Felipe Bernardes-SilvaAntonio A Laudanna
Feb 3, 2005·Gastroenterology·Christophe CorpechotRaoul Poupon
Jun 2, 2005·Journal of the National Cancer Institute·David S AlbertsUNKNOWN Phoenix and Tucson Gastroenterologist Networks

❮ Previous
Next ❯

Citations

May 18, 2012·The Cochrane Database of Systematic Reviews·Ronald L KoretzTimothy O Lipman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.